Ravi Sachdev

Mr. Sachdev joined Clayton Dubilier & Rice in 2015. He plays a key role in the Firm’s investments in agilon health, Vets First Choice, Tranzact, and Healogics.

Previously, he served as a Managing Director and Co-Head of Healthcare Services at J.P. Morgan, advising senior healthcare company executives on strategic initiatives, M&A and capital markets. In that role, Mr. Sachdev advised on multiple transactions including the sale of Medco to Express Scripts, Vanguard to Tenet, Trizetto to Cognizant, and the IPOs of HealthEquity, SCA, Premier, and IMS Health.

He received his B.A. in Economics from the University of Michigan.